Deer can die from the stress of being caught
Chase and restrain a wild deer or kangaroo and its muscles can break down from the strain, sometimes fatally. Vets call it capture myopathy. It belongs to a sprawling family of disorders in which the fault lies in the muscle fibres themselves, not in the nerves or brain that drive them.
The word joins the Greek for muscle and suffering. What unites myopathies is that the muscle fibres fail at their own job, typically producing pain, weakness or fatigue that sets in faster than normal, along with cramps, stiffness or contractures. Over years a diseased muscle may waste away, or paradoxically swell into a falsely athletic look. Causes range from inherited faults to infections, immune attack, drugs and toxins, and some remain unexplained.
The mechanisms differ widely. In muscular dystrophies, faulty genes weaken the membrane and internal scaffolding of muscle cells, which degenerate and regenerate until repair gives out. Channelopathies disturb the ion channels that fire each contraction. Metabolic myopathies starve the cell of ATP, its energy currency, so symptoms flare with exercise rather than staying constant. Congenital forms leave telltale microscopic marks, such as rod-like bodies in nemaline myopathy or nuclei stranded at the centre of fibres. Toxins matter too: horses can develop atypical myopathy from eating sycamore seeds and seedlings, and steroid drugs of the glucocorticoid class speed protein breakdown and shrink muscle.
No single test settles a diagnosis. Blood creatine kinase is the usual marker of muscle damage, but a high level alone reveals little. Electromyography helps separate muscle from nerve disease, MRI can survey deep muscles and pick a biopsy site, and biopsy remains central for inflammatory and structural types. Genetic panels increasingly confirm inherited forms without cutting tissue at all. The immune-driven myositis group includes dermatomyositis, which adds a reddish rash around the eyes and over the knuckles, and inclusion body myositis, which slowly weakens grip and knee straightening and has no proven treatment.
Medicines can be culprits. The US Food and Drug Administration told doctors to restrict the 80 mg dose of the cholesterol drug simvastatin because of muscle damage risk. A published case report described a man whose sudden weakness turned out to be the first sign of Burkitt lymphoma; his strength returned quickly once chemotherapy began.
Source: Myopathy
